Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Study completedNCT00107419What this trial is testingS0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic ChondrosarcomaWho this might be right forSarcoma SWOG Cancer Research Network 75
Testing effectiveness (Phase 2)WithdrawnNCT04648826What this trial is testingAerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWho this might be right forSarcomasMelanomasGerm Cell Tumors+2 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT04902443What this trial is testingPomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVWho this might be right forViral Associated MalignanciesKaposi SarcomaEBV/KSHV-associated Lymphomas National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00031915What this trial is testingImatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT04032964What this trial is testingDose Finding Study of L19TNF and Doxorubicin in Patients With STSWho this might be right forSoft Tissue Sarcoma Philogen S.p.A. 2
Testing effectiveness (Phase 2)Looking for participantsNCT07153887What this trial is testingVebreltinib for Advanced or Metastatic CCSWho this might be right forClear Cell Sarcoma (CCS) Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00526149What this trial is testingBI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsWho this might be right forBreast CancerEndometrial CancerHead and Neck Cancer+3 more European Organisation for Research and Treatment of Cancer - EORTC 76
Large-scale testing (Phase 3)Ended earlyNCT03520959What this trial is testingA Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)Who this might be right forSynovial SarcomaCancerSoft Tissue Sarcoma+2 more Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 1
Early research (Phase 1)Study completedNCT00562380What this trial is testingAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaWho this might be right forLymphomaProstate CancerSarcoma+2 more Amgen 64
Testing effectiveness (Phase 2)Ended earlyNCT04383210What this trial is testingStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more Elevation Oncology 54
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT05830123What this trial is testingARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other SarcomasWho this might be right forOsteosarcomaSarcoma Hansoh BioMedical R&D Company 170
Testing effectiveness (Phase 2)Study completedNCT05938374What this trial is testingPreoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)Who this might be right forSoft Tissue Sarcoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Testing effectiveness (Phase 2)Looking for participantsNCT06721689What this trial is testingPEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsWho this might be right forRefractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more Theodore Laetsch 59
Early research (Phase 1)Not Yet RecruitingNCT05361954What this trial is testingStudy to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid TumorsWho this might be right forCancerCancer of PancreasSarcoma+2 more Sorrento Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT03220035What this trial is testingVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00019968What this trial is testingIsolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or LegWho this might be right forStage IVB Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue Sarcoma+3 more National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868What this trial is testingAPG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsWho this might be right forUnresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more Ascentage Pharma Group Inc. 230
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64